| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 0 | 0 | 0 | 18.770 | 22.074 | 25.953 |
| Total Income - EUR | - | - | - | - | 0 | 0 | 0 | 18.770 | 22.074 | 25.953 |
| Total Expenses - EUR | - | - | - | - | 0 | 0 | 0 | 7.230 | 13.834 | 19.674 |
| Gross Profit/Loss - EUR | - | - | - | - | 0 | 0 | 0 | 11.540 | 8.240 | 6.278 |
| Net Profit/Loss - EUR | - | - | - | - | 0 | 0 | 0 | 10.977 | 8.020 | 5.500 |
| Employees | - | - | - | - | 0 | 0 | 0 | 0 | 1 | 1 |
Check the financial reports for the company - Adidiab Medical S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 63 | 62 | 61 | 61 | 61 | 60 |
| Current Assets | - | - | - | - | 42 | 41 | 40 | 11.157 | 14.049 | 12.545 |
| Inventories | - | - | - | - | 0 | 0 | 0 | 109 | 109 | 481 |
| Receivables | - | - | - | - | 0 | 0 | 0 | 1.008 | 1.385 | 660 |
| Cash | - | - | - | - | 42 | 41 | 40 | 10.039 | 12.555 | 11.405 |
| Shareholders Funds | - | - | - | - | 42 | 41 | 40 | 11.018 | 13.247 | 11.396 |
| Social Capital | - | - | - | - | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | 63 | 62 | 61 | 200 | 863 | 1.210 |
| Income in Advance | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Adidiab Medical S.r.l.